The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

According to a published report in the Wall St. Journal, Glaxo Smith Kline became the latest drug manufacturer to add a warning label to its ADHD drug, Dexedrine. The new warning label will include a warning about cardiac risks and psychiatric side effects. The new warning was posted on the FDA website yesterday.

Comments are closed.

Of Interest